Related Experiment Video
Updated: Jun 11, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Recent insights into contributing factors in the pathogenesis of cirrhotic ascites
Zhen Li1, Junfeng Zhu1,2, Hao Ouyang1
1Department of Hepatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Insights
Cirrhotic ascites, fluid accumulation from liver disease, lacks effective treatments. This study explores its complex pathogenesis, including portal hypertension and gut microbiota, for better understanding.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Cirrhotic ascites is fluid accumulation in the peritoneal cavity due to severe liver disease and impaired function.
- It is a common cirrhosis complication, posing significant health threats and social burdens globally.
- Current treatments only manage symptoms and slow progression, lacking curative options.
Purpose of the Study:
- To examine the pathogenesis of cirrhotic ascites.
- To explore contributing factors including portal hypertension, renal dysfunction, inflammation, growth factors, oxidative stress, immunocytes, and gut microbiota.
- To gain deeper insights into the mechanisms underlying cirrhotic ascites.
Main Methods:
- Literature review and synthesis of existing research on cirrhotic ascites.
- Analysis of factors contributing to fluid accumulation and disease progression.
- Exploration of the interplay between various pathophysiological mechanisms.
Main Results:
- Cirrhotic ascites results from complex interactions including portal hypertension, altered hemodynamics, and fluid exudation.
- Renal dysfunction, inflammation, oxidative stress, and immune cell activity play crucial roles.
- Gut microbiota dysbiosis is increasingly recognized as a significant contributing factor.
Conclusions:
- Understanding the multifaceted pathogenesis of cirrhotic ascites is critical for developing effective therapeutic strategies.
- Targeting factors like portal hypertension, inflammation, and gut microbiota may offer new treatment avenues.
- Further research into these mechanisms is essential to improve patient outcomes and quality of life.
Abstract:
Cirrhotic ascites refers to the accumulation of fluid in the peritoneal cavity due to severe liver disease and impaired liver function, which leads to poor blood circulation in the body, increased pressure in the hepatic sinus wall, and the exudation of fluid from the plasma into the peritoneal cavity. Cirrhotic ascites is a common complication of cirrhosis and poses a threat to the health and lives of modern people, causing a heavy social burden worldwide. So far, there are no effective treatment methods available to improve the quality and quantity of life for patients and their partners; existing drugs can only alleviate the symptoms of cirrhotic ascites and slow down its progression. This article aims to carefully examine the pathogenesis of cirrhotic ascites by exploring various contributing factors such as portal hypertension, renal dysfunction, inflammation, growth factors, oxidative stress, immunocytes, and gut microbiota. The purpose is to gain better insights and deeper understanding of the mechanisms involved in this condition.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

